H. Falkson

R. Gray, D. Tormey, K. Gilchrist, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Specialist Interest Articles Long-term Survival of Patients Treated with Combination Chemotherapy for Metastatic Breast Cancer

D. Tormey, G. Falkson, H. Falkson, 1991 .

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.

R. Gray, A. Recht, B. Fowble, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer.

J. Raats, G. Falkson, H. Falkson, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment and prognosis of metastatic carcinoma of unknown primary: analysis of 100 patients.

G. Falkson, H. Falkson, A. Alberts, 1989, Medical and pediatric oncology.

A Randomized Trial of Mitomycin‐C (M) Versus Mitomycin‐C Plus High‐Dose Medroxyprogesterone Acetate (MMPA) in the Treatment of Patients with Advanced Breast Cancer

C. Falkson, G. Falkson, H. Falkson, 1993, American journal of clinical oncology.

FIVB plus GM-CSF in metastatic colorectal cancer

C. Falkson, G. Falkson, H. Falkson, 2004, Investigational New Drugs.

Prognostic factors affecting the survival of patients with multiple myeloma. A retrospective analysis of 86 patients.

B. Rapoport, G. Falkson, H. Falkson, 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

CAF and nasal buserelin in the treatment of premenopausal women with metastatic breast cancer.

G. Falkson, H. Falkson, 1989, European journal of cancer & clinical oncology.

Non‐Hodgkin's lymphoma in pregnancy

I. Simson, G. Falkson, H. Falkson, 1980, Cancer.

Malignant pleural mesothelioma treatment: the current state of the art.

G. Falkson, H. Falkson, A. Alberts, 1988, Cancer treatment reviews.

Phase II trial of fotemustine in patients with metastatic malignant melanoma

C. Falkson, G. Falkson, H. Falkson, 2004, Investigational New Drugs.

Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.

G. Falkson, H. Falkson, A. M. van der Merwe, 1972, Cancer chemotherapy reports.

A clinical trial of the oral form of 4′‐demethyl‐epipodophyllotoxin‐β‐D ethylidene glucoside (NSC 141540) VP 16–213

J. Van Dyk, G. Falkson, H. Falkson, 1975 .

Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy.

C. Falkson, H. Falkson, 1995, Oncology.

A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer

G. Falkson, H. Falkson, 2004, Cancer Chemotherapy and Pharmacology.

Combined telecobalt and 5-fluorouracil therapy in carcinoma of the pancreas: a report of 97 cases.

G. Falkson, H. Falkson, T. Fichardt, 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects

S. Moss, P. Carbone, D. Tormey, 1986, Cancer.

Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.

C. Loprinzi, D. Tormey, G. Falkson, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of spirogermanium for treatment of advanced breast cancer.

G. Falkson, H. Falkson, 1983, Cancer treatment reports.

Unexpected toxicity in patients treated with iphosphamide.

J. Van Dyk, G. Falkson, H. Falkson, 1972, Cancer research.

Long term follow-up of patients with advanced prostatic cancer treated with nasal buserelin.

C. Falkson, G. Falkson, H. Falkson, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer

M. Chasen, G. Falkson, H. Falkson, 1990, Investigational New Drugs.

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector

C. Falkson, G. Falkson, H. Falkson, 1989, Investigational New Drugs.

Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment

G. Falkson, H. Falkson, J. V. Dyk, 2004, Cancer Chemotherapy and Pharmacology.

Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer.

C. Falkson, G. Falkson, H. Falkson, 1991, European journal of cancer.

Prognostic Factors in Metastatic Malignant Melanoma

C. Falkson, H. Falkson, 1997, Oncology.

Vindesine. A phase II trial in advanced breast cancer patients.

J. Crowley, D. Tormey, G. Ramírez, 1981, Cancer clinical trials.

High‐Dose Medroxyprogesterone Acetate plus Mitomycin‐C or Vindesine in the Treatment of Advanced Breast Cancer

C. Falkson, G. Falkson, H. Falkson, 1988, American journal of clinical oncology.

Further experience with isophosphamide.

G. Falkson, H. Falkson, 1976, Cancer treatment reports.

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.

R. Weiss, D. Tormey, J. Holland, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Locoregional F ailure 1 0 Y ears A fter M astectomy and A djuvant C hemotherapy W ith o r W ithout T amoxifen Without I rradiation: E xperience o f t he E astern Cooperative O ncology G roup

R. Gray, A. Recht, B. Fowble, 1999 .

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer.

C. Falkson, H. Falkson, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer

J. Raats, G. Falkson, H. Falkson, 1992, The Journal of Steroid Biochemistry and Molecular Biology.

Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus the treatment of premenopausal women with metastatic breast cancer

C. Falkson, G. Falkson, H. Falkson, 1992 .

Pyridine nucleotides in cancer.

G. Falkson, H. Falkson, 1965, Lancet.

Fluorouracil, methyl‐ccnu and vincristine in cancer of the colon

G. Falkson, H. Falkson, 1976, Cancer.

CHROMOMYCIN A 3 (TOYOMYCIN) AND RADIOTHERAPY IN THE TREATMENT OF ADVANCED MALIGNANCY

H. Falkson, A. Sandison, T. Fichardt, 1966 .

Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy. A study by cancer and leukemia group B

J. Holland, G. Falkson, O. Glidewell, 1979, Cancer.

A five-drug combination in the treatment of metastatic breast cancer.

G. Falkson, H. Falkson, 1981, Cancer clinical trials.

High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting

C. Falkson, G. Falkson, H. Falkson, 1990, Investigational New Drugs.

5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.

J. Van Dyk, G. Falkson, H. Falkson, 1972, Cancer chemotherapy reports.

Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin.

C. Falkson, G. Falkson, H. Falkson, 1996, Oncology.

Dibromodulcitol in the treatment of breast cancer.

G. Falkson, H. Falkson, L. Pretorius, 1982, Cancer treatment reviews.

Adriamycin in the treatment of cancer.

J. Van Dyk, G. Falkson, H. Falkson, 1976, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

High-dose medroxyprogesterone acetate in combination with vindesine in advanced breast cancer.

G. Falkson, H. Falkson, 1986, European journal of cancer & clinical oncology.

Natulan (Procarbazine) combined with radiotherapy in management of inoperable malignant melanoma.

G. Falkson, H. Falkson, P. D. de Villiers, 1965, British medical journal.

Acute leukemia as a complication of long-term treatment of advanced breast cancer.

G. Falkson, H. Falkson, M. Portugal, 1979, Cancer treatment reports.

Seasonal Onset of Hodgkin's Disease

H. Falkson, 1965, British medical journal.